IDO1 and classic Hodgkin lymphoma: Conversely, the levels of PD-L1+ tumor cells, or TAM-negative for PD-L1 and IDO were not associated with a bad outcome, suggesting that the immunophenotype of TAMs, rather than their quantity, can affect the survival of cHL patients.